MARIAN FINEHIRSH: Open Payments
NPI 1568410074 · CLEARWATER, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,672 in 167 payments from 29 companies in 2025. Trend: 2023 $4,458 · 2024 $5,754 · 2025 $5,672
Food & beverage: $5,522Consulting: $150
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $660 |
| Lundbeck LLC | 15 | $578 |
| Novartis Pharmaceuticals Corporation | 9 | $509 |
| Eisai Inc. | 5 | $372 |
| PFIZER INC. | 13 | $344 |
| Neurocrine BioSciences, Inc. | 9 | $338 |
| MDD US Operations, LLC | 11 | $338 |
| Otsuka America Pharmaceutical, Inc. | 2 | $326 |
| EMD Serono, Inc. | 3 | $276 |
| Merz Pharmaceuticals, LLC | 13 | $249 |
Products named: KESIMPTA, VYEPTI, REXULTI, Leqembi, NURTEC ODT, INGREZZA, ZEPOSIA, QULIPTA.
Industry payments across FL — which companies pay providers there.
